Abstract:
The present invention relates to methods of detection, as well as assays, reagents and kits for the specific detection of clinically important bacterial and fungal species. The present invention allows for the specific detection of nucleic acids of each of these pathogens in a single assay.
Abstract:
Biomarkers associated with preeclampsia were identified. Nine proteins were identified as being differentially regulated between the control and the under 28-weeks preeclamptic samples. Similarly three proteins were identified as being differentially regulated between the control and the over 28-weeks preeclamptic samples. These 12 proteins can be used as potential biomarkers in the diagnosing and prognosing of preeclampsia.
Abstract:
Aspects described and claimed herein provide methods to insert multiple DNA adaptors into a population of circular target DNAs at defined positions and orientations with respect to one another. The resulting multi-adaptor constructs are then used in massively-parallel nucleic acid sequencing techniques.
Abstract:
Methods for diagnosing or detecting cancerous colon tissue. A panel of 21 specific marker genes are provided with GeneBank Accession Numbers as follows: M77836, X63468, H20426, L18960, U30872, X81438, H67367, Dl 3645, R33367, T94834, L20852, R39540, H86039, T78477, T84082, X05610, R39130, T49397, T94350, L42611 and M33653. The overexpression of some of these marker genes compared to their expression in normal colon tissue and the underexpression of the rest of these marker genes are indicative of cancerous colon tissue. By using these 21 marker genes as a diagnostic tool, smaller tissue samples, such as those obtained by core needle biopsies and from patient stool samples, can be used.
Abstract:
A method for designing a combinatorial library of samples comprises:(l) providing an abstract formula, wherein the abstract formula comprises at least one member and variable corresponding to each member;(2) providing at least one selectable component for each member; (3) providing at least one selectable value for each variable; (4) providing at least one constraint for the variable;(5) generating at least one combination of variables by determining the value of each variable in the abstract formula;(6) identifying at least one combination which meets the constraint; and (7) associating variables in the combination which meets the constraint with corresponding members.
Abstract:
Assay supports, such as microarrays and similar devices, and methods of use and manufacture thereof, are described. The assay support is capable of assaying binding and/or activity of a bioactive entity, such as a bioactive molecule or a cell. Analytical and diagnostic uses of the supports are also described.
Abstract:
Systems, methods, apparatus, and computer programming useful in identifying proteins, peptides, carbohydrates, and other biomolecules, or for a validation of an identification of proteins, peptides, carbohydrates, and other biomolecules, is described. In particular, the invention provides systems, methods, apparatus, and programming useful for identifying proteins and other precursor biomolecules using expression patterns associated with peptides or other biomolecule fragments expressed from analyte samples, and data representing such expression patterns, and for determining and improving confidence levels associated with identification of precursor biomolecules using such methods, through the correlation of expression patterns for fragments associated with precursor biomolecules.
Abstract:
The present invention relates to a method for identification and isolation of binding molecules having a selective affinity for a ligand. More specifically, this invention provides a process for the ultra high throughput screening of binding molecules from expression libraries containing billions of independent clones without the biases and limitations of other high throughput screening methods such as panning. Additionally, the present invention provides a method for the production of expression libraries essentially free of clones encoding non-functional molecules.
Abstract:
The present invention provides systems, methods, screens, reagents and kits for optical system analysis of cells to rapidly determine the distribution, environment, or activity of fluorescently labeled reporter molecules in cells for the purpose of screening large numbers of compounds for those that specifically affect particular biological functions.
Abstract:
A method is provided for use in solid phase chemical synthesis such as in the synthesis of polypeptides, peptoids, and other molecules synthesized by solid phase methods. The method is used to identify compounds having activity against a selected target, wherein the compounds are present in a mixture obtained from a combinatorial library. A bead distributor probe is also provided. The probe is used to extract beads from a population of beads, and then deliver the bead to a selected location. A capillary bead insert is also provided, as well as a bead distribution system which includes both a bead distributor probe and a capillary bead insert.